Our goal is to support people on their journey to recovery and enhance their wound-free of life. SynerHeal Pharmaceuticals was created with a vision to heal patients’ illness through affordable healthcare products. We believe this can be achieved by translating innovative cost effective technologies to healthcare products. The core team of SynerHeal has experts with immense experience in clinical practice, pharmaceutical research and development, quality manufacturing and marketing. We are committed to the development of clinically effective and affordable healthcare management products in various therapeutic classes SynerHeal wound care business segment offers synergistic wound care therapeutics to promote faster healing of hard to heal wounds like diabetic wounds, venous leg ulcers and pressure sores, first and second degree burns that affect a large population. Advanced wound care products for the management of chronic wounds have been developed in collaboration with Central Leather Research Institute, a pioneer name having a rich history in developing wound healing therapeutics. Our shared knowledge from the best of scientists who provide the R&D inputs, combined with expert clinicians gives us an edge in understanding the clinical need for the management of wounds. Advances in wound care treatment have been incompletely applied in low- and middle-income countries, especially in India. SynerHeal advanced wound management segment focuses at making advanced wound care accessible to all patients across the socioeconomic spectrum. SynerHeal is committed to adopt good manufacturing practices for the manufacturing, quality testing and quality assurance of pharmaceutical dosage forms. Innovation and quality manufacturing practice are the main driving forces behind the sustainable growth of SynerHeal.
